More News
2 November 2020
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance Therapeutic Development2 November 2020
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products23 October 2020
Retrophin Announces Agreement to Acquire Orphan Technologies20 October 2020
CEVEC and Rznomics sign license agreement for the use of CAP® Technology in manufacturing of adenoviral vectors19 October 2020
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech15 October 2020
Lilly Announces Agreement to Acquire Disarm Therapeutics13 October 2020
Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies7 October 2020
Janpix Announces $10 Million Series B Financing to Advance STAT Protein Degrader Pipeline6 October 2020
Chugai Enters into a License Agreement for Chugai’s Antibody Engineering Technologies with argenxNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports